Wird geladen...
Hippocampal Injections of Oligomeric Amyloid β-peptide (1–42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway
Increasing evidence suggests that abnormal brain accumulation of soluble rather than aggregated amyloid-β(1–42) oligomers (Aβo((1–42))) plays a causal role in Alzheimer’s disease (AD). However, as yet, animal’s models of AD based on oligomeric amyloid-β(1–42) injections in the brain have not investi...
Gespeichert in:
| Veröffentlicht in: | Front Aging Neurosci |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707555/ https://ncbi.nlm.nih.gov/pubmed/26793098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2015.00245 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|